Patent · US Active

Ureas and their use in the treatment of heart failure

US8871769B2 · kind B2 · utility

27Cited by

37References

1Claims

0Family size

Assignee

CYTOKINETICS, INC. · US

Inventors

Bradley P. Morgan · Moraga, US
Alex Muci · South San Francisco, US
Pu-Ping Lu · Foster City, US
Erica Anne Kraynack · South San Francisco, US
Todd Tochimoto · Foster City, US
David J. Morgans, Jr. · Los Altos, US

Key dates

Filing date	Jul 19, 2013
Grant date	Oct 28, 2014
Priority date	—
Expiry date	Jul 19, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.